SCHEMBL5488766

SCHEMBL5488766

CNC(=O)C(OC)N1CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 6/20 0.38
SIGMAR1 Q99720 2/20 0.35
CHRM5 P08912 1/20 0.34
CHRM3 P20309 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
OPRM1 P35372 1/20 0.32
PADI1 Q9ULC6 1/20 0.31
PADI4 Q9UM07 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
TPSAB1 Q15661 1/20 0.30
TPSD1 Q9BZJ3 1/20 0.30
TPSG1 Q9NRR2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4974751 0.98 OPRD1 (0.38) OPRD1SIGMAR1CHRM5CHRM3MEN1
SCHEMBL4557392 0.81 OPRD1 (0.42) OPRD1SIGMAR1CHRM5CHRM3MEN1
SCHEMBL4558787 0.79 POLB (0.51) OPRD1MEN1KMT2A
SCHEMBL11064005 0.76 SIGMAR1 (0.51) OPRD1SIGMAR1CHRM5CHRM3MEN1
SCHEMBL5504463 0.73 SIGMAR1 (0.39) OPRD1SIGMAR1CHRM5CHRM3CA12
SCHEMBL21815527 0.70 OPRD1 (0.39) OPRD1OPRM1
SCHEMBL29952348 0.70 OPRD1 (0.35) OPRD1SIGMAR1CHRM5CHRM3MEN1
SCHEMBL1417902 0.69 OPRD1 (0.42) OPRD1SIGMAR1CHRM5CHRM3MEN1
SCHEMBL3624302 0.69 OPRD1 (0.52) OPRD1SIGMAR1MEN1KMT2AOPRM1
SCHEMBL6603037 0.68 SIGMAR1 (0.44) OPRD1SIGMAR1CHRM5CHRM3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861376-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F. Hoffmann-Roche AG (CH) 2007-12-05 EP disclosed
EP-1753727-A1 NOVEL CIS-IMIDAZOLINES F.HOFFMANN-LA ROCHE AG (CH) 2007-02-21 EP disclosed
WO-2006097261-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-21 WO disclosed
WO-2005110996-A1 NOVEL CIS-IMIDAZOLINES F.HOFFMANN-LA ROCHE AG (CH) 2005-11-24 WO disclosed